The authors concluded that the NF-κB-driven signal from within the tumor cells promotes a M1/Th1 microenvironment; these cells then produce their own signals, which enhance and maintain this effect and influence responses to chemotherapy and overall outcome. The gene discussed is NFKB1; the disease is neoplasm.